New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2014
11:14 EDTATHN, MYL, ISRGOptions with increasing implied volatility: ATHN ISRG MYL
News For ATHN;ISRG;MYL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 31, 2015
09:50 EDTMYLMylan launches generic Exforge tablets in U.S.
Subscribe for More Information
March 30, 2015
13:01 EDTMYLOptions with increasing volume
Subscribe for More Information
10:46 EDTMYLOptions with increasing implied volatility
Subscribe for More Information
10:24 EDTMYLMylan volatility up after filing to sell 35M shares for Abbott Laboratories
Subscribe for More Information
09:27 EDTMYLOn The Fly: Pre-market Movers
Subscribe for More Information
09:15 EDTMYLTeva does not rule out bigger deal if opportunity arises
Subscribe for More Information
09:02 EDTMYLMylan slips amid Abbott share sale, Teva deal for Auspex
Subscribe for More Information
07:37 EDTISRGJefferies still 'constructive' on Intuitive Surgical after doctor survey
Subscribe for More Information
06:34 EDTMYLMylan files to sell 35M shares of stock for Abbott Laboratories subsidiaries
Subscribe for More Information
March 27, 2015
15:14 EDTISRGJohnson & Johnson not likely to buy Intuitive Surgical, says BofA/Merrill
Subscribe for More Information
07:45 EDTMYLFDA to hold a public meeting
Subscribe for More Information
07:25 EDTMYLTeva appears to be weighing transformative deal, says Bernstein
After attending Teva's (TEVA) meeting with investors, Bernstein thinks that the company is considering making a 'transformative' acquisition, although it believes that such a deal may not be imminent. The firm sees Mylan ((MYL) and the generic units of Actavis (ACT), Pfizer (PFE), and possibly Valeant (VRX) as the four logical candidates. It says that Teva can pay $81 per share for Mylan, and that a takeover of Mylan would raise Teva's EPS to about $6.50 in 2017 and $7 in 2018. Bernstein raised its price target on Teva to $69 from $60 and keeps an Outperform rating on the shares.
March 25, 2015
15:27 EDTATHNathenahealth volatility at low end of historic range
athenahealth March weekly call option implied volatility is at 34, April is at 32, May is at 35, June is at 32; compared to its 26-week average of 38 according to Track Data, suggesting decreasing price movement.
13:15 EDTATHNathenahealth management to meet with Stephens
Subscribe for More Information
10:51 EDTISRGOptions with increasing implied volatility
Options with increasing implied volatility: CLDN CMG CREE AMZN ISRG MAC UA VMW SLXP
07:12 EDTATHNAmerican Academy of Orthopedic Surgeons to hold annual meeting
Subscribe for More Information
March 24, 2015
10:40 EDTISRGOptions with increasing implied volatility
Subscribe for More Information
10:32 EDTISRGOptions with increasing implied volatility
Options with increasing implied volatility: MAC CMG HLSS PSEC ISRG AMZN CREE
March 23, 2015
10:01 EDTATHNathenahealth management to meet with SunTrust
Subscribe for More Information
March 19, 2015
06:15 EDTATHNathenahealth coverage transferred with an Outperform at RW Baird
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use